Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J A Kummer

Showing results (41-50 of 43) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 43 results.
The Journal of Experimental Medicine|September 6, 2001
Expression of the serpin serine protease inhibitor 6 protects dendritic cells from cytotoxic T lymphocyte-induced apoptosis: differential modulation by T helper type 1 and type 2 cellsJ P Medema, D H Schuurhuis, D Rea, et al.
Leukemia|January 9, 2004
Prognostic significance of activated cytotoxic T-lymphocytes in primary nodal diffuse large B-cell lymphomasJ J F Muris, C J L M Meijer, S A G M Cillessen, et al.
Endocrine-Related Cancer|October 5, 2007
DNA copy number status is a powerful predictor of poor survival in endocrine pancreatic tumor patientsY M H Jonkers, S M H Claessen, A Perren, et al.
Pageof 5

Showing results (41-50 of 43) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 43 results.
The Journal of Experimental Medicine|September 6, 2001
Expression of the serpin serine protease inhibitor 6 protects dendritic cells from cytotoxic T lymphocyte-induced apoptosis: differential modulation by T helper type 1 and type 2 cellsJ P Medema, D H Schuurhuis, D Rea, et al.
Leukemia|January 9, 2004
Prognostic significance of activated cytotoxic T-lymphocytes in primary nodal diffuse large B-cell lymphomasJ J F Muris, C J L M Meijer, S A G M Cillessen, et al.
Endocrine-Related Cancer|October 5, 2007
DNA copy number status is a powerful predictor of poor survival in endocrine pancreatic tumor patientsY M H Jonkers, S M H Claessen, A Perren, et al.
Pageof 5